Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2125 entries
Sorted by: Best Match Show Resources per page
[Drug safety. Introduction to the topic].

Der Internist

Dölle W, Sewing KF.
PMID: 352980
Internist (Berl). 1978 Jun;19(6):325.

No abstract available.

Cite
Dölle W, Sewing KF. Arzneimittelsicherheit. Einführung zum Thema. [Drug safety. Introduction to the topic]. Internist (Berl). 1978;19(6):325
Dölle, W., & Sewing, K. F. (1978). Arzneimittelsicherheit. Einführung zum Thema. [Drug safety. Introduction to the topic]. Der Internist, 19(6), 325.
Dölle, W, and Sewing, K F. "Arzneimittelsicherheit. Einführung zum Thema." [Drug safety. Introduction to the topic]. Der Internist vol. 19,6 (1978): 325.
Dölle W, Sewing KF. Arzneimittelsicherheit. Einführung zum Thema. [Drug safety. Introduction to the topic]. Internist (Berl). 1978 Jun;19(6):325. German. PMID: 352980.
Copy Download .nbib Format: NLM
Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?.

Therapeutic advances in drug safety

Hartholt KA, Becker ML, van der Cammen TJ.
PMID: 27034772
Ther Adv Drug Saf. 2016 Apr;7(2):39-42. doi: 10.1177/2042098615627806. Epub 2016 Jan 20.

BACKGROUND: Falls are the leading cause of injuries among older persons. Because of ageing societies worldwide, falls are expected to become a prominent public health problem. The usage of several types of drugs has been associated with an increased...

Cite
Hartholt KA, Becker ML, van der Cammen TJ. Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?. Ther Adv Drug Saf. 2016;7(2):39-42doi: 10.1177/2042098615627806.
Hartholt, K. A., Becker, M. L., & van der Cammen, T. J. (2016). Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?. Therapeutic advances in drug safety, 7(2), 39-42. https://doi.org/10.1177/2042098615627806
Hartholt, Klaas A, et al. "Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?." Therapeutic advances in drug safety vol. 7,2 (2016): 39-42. doi: https://doi.org/10.1177/2042098615627806
Hartholt KA, Becker ML, van der Cammen TJ. Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?. Ther Adv Drug Saf. 2016 Apr;7(2):39-42. doi: 10.1177/2042098615627806. Epub 2016 Jan 20. PMID: 27034772; PMCID: PMC4785859.
Copy Download .nbib Format: NLM
Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance.

Therapeutic advances in drug safety

Dore DD, Seeger JD, Chan KA.
PMID: 25083233
Ther Adv Drug Saf. 2012 Aug;3(4):157-64. doi: 10.1177/2042098612446473.

OBJECTIVES: As part of a regulatory postmarketing commitment, we assessed the risk of claims for thyroid and pancreatic cancer among users of exenatide using an active drug safety surveillance system.METHODS: This active surveillance assessment used cohort methodology and commercial...

Cite
Dore DD, Seeger JD, Chan KA. Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance. Ther Adv Drug Saf. 2012;3(4):157-64doi: 10.1177/2042098612446473.
Dore, D. D., Seeger, J. D., & Chan, K. A. (2012). Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance. Therapeutic advances in drug safety, 3(4), 157-64. https://doi.org/10.1177/2042098612446473
Dore, David D, et al. "Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance." Therapeutic advances in drug safety vol. 3,4 (2012): 157-64. doi: https://doi.org/10.1177/2042098612446473
Dore DD, Seeger JD, Chan KA. Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance. Ther Adv Drug Saf. 2012 Aug;3(4):157-64. doi: 10.1177/2042098612446473. PMID: 25083233; PMCID: PMC4110848.
Copy Download .nbib Format: NLM
High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?.

Therapeutic advances in drug safety

Dreischulte T, Guthrie B.
PMID: 25083235
Ther Adv Drug Saf. 2012 Aug;3(4):175-84. doi: 10.1177/2042098612444867.

The safety of medication use in primary care is an area of increasing concern for health systems internationally. Systematic reviews estimate that 3-4% of all unplanned hospital admissions are due to preventable drug-related morbidity, the majority of which have...

Cite
Dreischulte T, Guthrie B. High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?. Ther Adv Drug Saf. 2012;3(4):175-84doi: 10.1177/2042098612444867.
Dreischulte, T., & Guthrie, B. (2012). High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?. Therapeutic advances in drug safety, 3(4), 175-84. https://doi.org/10.1177/2042098612444867
Dreischulte, Tobias, and Guthrie, Bruce. "High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?." Therapeutic advances in drug safety vol. 3,4 (2012): 175-84. doi: https://doi.org/10.1177/2042098612444867
Dreischulte T, Guthrie B. High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?. Ther Adv Drug Saf. 2012 Aug;3(4):175-84. doi: 10.1177/2042098612444867. PMID: 25083235; PMCID: PMC4110851.
Copy Download .nbib Format: NLM
The ABCD of clinical pharmacokinetics.

Therapeutic advances in drug safety

Doogue MP, Polasek TM.
PMID: 25083246
Ther Adv Drug Saf. 2013 Feb;4(1):5-7. doi: 10.1177/2042098612469335.

No abstract available.

Cite
Doogue MP, Polasek TM. The ABCD of clinical pharmacokinetics. Ther Adv Drug Saf. 2013;4(1):5-7doi: 10.1177/2042098612469335.
Doogue, M. P., & Polasek, T. M. (2013). The ABCD of clinical pharmacokinetics. Therapeutic advances in drug safety, 4(1), 5-7. https://doi.org/10.1177/2042098612469335
Doogue, Matthew P, and Polasek, Thomas M. "The ABCD of clinical pharmacokinetics." Therapeutic advances in drug safety vol. 4,1 (2013): 5-7. doi: https://doi.org/10.1177/2042098612469335
Doogue MP, Polasek TM. The ABCD of clinical pharmacokinetics. Ther Adv Drug Saf. 2013 Feb;4(1):5-7. doi: 10.1177/2042098612469335. PMID: 25083246; PMCID: PMC4110820.
Copy Download .nbib Format: NLM
Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies.

Therapeutic advances in drug safety

Madigan D, Ryan PB, Schuemie M.
PMID: 25083251
Ther Adv Drug Saf. 2013 Apr;4(2):53-62. doi: 10.1177/2042098613477445.

BACKGROUND: Clinical studies that use observational databases, such as administrative claims and electronic health records, to evaluate the effects of medical products have become commonplace. These studies begin by selecting a particular study design, such as a case control,...

Cite
Madigan D, Ryan PB, Schuemie M. Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies. Ther Adv Drug Saf. 2013;4(2):53-62doi: 10.1177/2042098613477445.
Madigan, D., Ryan, P. B., & Schuemie, M. (2013). Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies. Therapeutic advances in drug safety, 4(2), 53-62. https://doi.org/10.1177/2042098613477445
Madigan, David, et al. "Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies." Therapeutic advances in drug safety vol. 4,2 (2013): 53-62. doi: https://doi.org/10.1177/2042098613477445
Madigan D, Ryan PB, Schuemie M. Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies. Ther Adv Drug Saf. 2013 Apr;4(2):53-62. doi: 10.1177/2042098613477445. PMID: 25083251; PMCID: PMC4110833.
Copy Download .nbib Format: NLM
Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?.

Therapeutic advances in drug safety

Woodman RJ.
PMID: 25083258
Ther Adv Drug Saf. 2014 Feb;5(1):4-7. doi: 10.1177/2042098613517416.

No abstract available.

Cite
Woodman RJ. Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?. Ther Adv Drug Saf. 2014;5(1):4-7doi: 10.1177/2042098613517416.
Woodman, R. J. (2014). Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?. Therapeutic advances in drug safety, 5(1), 4-7. https://doi.org/10.1177/2042098613517416
Woodman, Richard J. "Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?." Therapeutic advances in drug safety vol. 5,1 (2014): 4-7. doi: https://doi.org/10.1177/2042098613517416
Woodman RJ. Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?. Ther Adv Drug Saf. 2014 Feb;5(1):4-7. doi: 10.1177/2042098613517416. PMID: 25083258; PMCID: PMC4110877.
Copy Download .nbib Format: NLM
Safety of new oral anticoagulant drugs: a perspective.

Therapeutic advances in drug safety

Vílchez JA, Gallego P, Lip GY.
PMID: 25083259
Ther Adv Drug Saf. 2014 Feb;5(1):8-20. doi: 10.1177/2042098613507945.

The recent development of new oral anticoagulants (NOACs) offers the possibility of efficacy, relative safety and convenience compared with warfarin. This could lead to greater patient compliance, with easier management and improved provision of thromboprophylaxis. Safety whilst using NOACs...

Cite
Vílchez JA, Gallego P, Lip GY. Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf. 2014;5(1):8-20doi: 10.1177/2042098613507945.
Vílchez, J. A., Gallego, P., & Lip, G. Y. (2014). Safety of new oral anticoagulant drugs: a perspective. Therapeutic advances in drug safety, 5(1), 8-20. https://doi.org/10.1177/2042098613507945
Vílchez, Juan Antonio, et al. "Safety of new oral anticoagulant drugs: a perspective." Therapeutic advances in drug safety vol. 5,1 (2014): 8-20. doi: https://doi.org/10.1177/2042098613507945
Vílchez JA, Gallego P, Lip GY. Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf. 2014 Feb;5(1):8-20. doi: 10.1177/2042098613507945. PMID: 25083259; PMCID: PMC4110875.
Copy Download .nbib Format: NLM
Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety.

Therapeutic advances in drug safety

Phillips CJ.
PMID: 25083266
Ther Adv Drug Saf. 2014 Jun;5(3):118-20. doi: 10.1177/2042098614523819.

No abstract available.

Cite
Phillips CJ. Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety. Ther Adv Drug Saf. 2014;5(3):118-20doi: 10.1177/2042098614523819.
Phillips, C. J. (2014). Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety. Therapeutic advances in drug safety, 5(3), 118-20. https://doi.org/10.1177/2042098614523819
Phillips, Cameron J. "Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety." Therapeutic advances in drug safety vol. 5,3 (2014): 118-20. doi: https://doi.org/10.1177/2042098614523819
Phillips CJ. Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety. Ther Adv Drug Saf. 2014 Jun;5(3):118-20. doi: 10.1177/2042098614523819. PMID: 25083266; PMCID: PMC4110855.
Copy Download .nbib Format: NLM
Muscle Injury After Intramuscular Administration of Diclofenac: A Case Report Supported by Magnetic Resonance Imaging.

Drug safety - case reports

Probst M, Kühn JP, Modeß C, Scheuch E, Seidlitz A, Hosten N, Siegmund W, Weitschies W.
PMID: 28343290
Drug Saf Case Rep. 2017 Dec;4(1):7. doi: 10.1007/s40800-017-0049-9.

Intramuscular injection of diclofenac is still frequently practiced, although there is ample evidence that the risk of local tissue intolerability is highly underestimated. The aim of this study was to evaluate local toxicity in a patient using magnetic resonance...

Cite
Probst M, Kühn JP, Modeß C, et al. Muscle Injury After Intramuscular Administration of Diclofenac: A Case Report Supported by Magnetic Resonance Imaging. Drug Saf Case Rep. 2017;4(1):7doi: 10.1007/s40800-017-0049-9.
Probst, M., Kühn, J. P., Modeß, C., Scheuch, E., Seidlitz, A., Hosten, N., Siegmund, W., & Weitschies, W. (2017). Muscle Injury After Intramuscular Administration of Diclofenac: A Case Report Supported by Magnetic Resonance Imaging. Drug safety - case reports, 4(1), 7. https://doi.org/10.1007/s40800-017-0049-9
Probst, Mareike, et al. "Muscle Injury After Intramuscular Administration of Diclofenac: A Case Report Supported by Magnetic Resonance Imaging." Drug safety - case reports vol. 4,1 (2017): 7. doi: https://doi.org/10.1007/s40800-017-0049-9
Probst M, Kühn JP, Modeß C, Scheuch E, Seidlitz A, Hosten N, Siegmund W, Weitschies W. Muscle Injury After Intramuscular Administration of Diclofenac: A Case Report Supported by Magnetic Resonance Imaging. Drug Saf Case Rep. 2017 Dec;4(1):7. doi: 10.1007/s40800-017-0049-9. PMID: 28343290; PMCID: PMC5366168.
Copy Download .nbib Format: NLM
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence.

Therapeutic advances in drug safety

Russo V, Rago A, Proietti R, Di Meo F, Antonio Papa A, Calabrò P, D'Onofrio A, Nigro G, AlTurki A.
PMID: 28255434
Ther Adv Drug Saf. 2017 Feb;8(2):67-75. doi: 10.1177/2042098616673990. Epub 2016 Oct 24.

The aim of our article is to provide a concise review for clinicians entailing the main studies that evaluated the efficacy and safety of target-specific oral anticoagulants (TSOAs) for thromboembolic stroke prevention in the real-world setting. Atrial fibrillation (AF)...

Cite
Russo V, Rago A, Proietti R, et al. Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence. Ther Adv Drug Saf. 2016;8(2):67-75doi: 10.1177/2042098616673990.
Russo, V., Rago, A., Proietti, R., Di Meo, F., Antonio Papa, A., Calabrò, P., D'Onofrio, A., Nigro, G., & AlTurki, A. (2017). Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence. Therapeutic advances in drug safety, 8(2), 67-75. https://doi.org/10.1177/2042098616673990
Russo, Vincenzo, et al. "Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence." Therapeutic advances in drug safety vol. 8,2 (2017): 67-75. doi: https://doi.org/10.1177/2042098616673990
Russo V, Rago A, Proietti R, Di Meo F, Antonio Papa A, Calabrò P, D'Onofrio A, Nigro G, AlTurki A. Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence. Ther Adv Drug Saf. 2017 Feb;8(2):67-75. doi: 10.1177/2042098616673990. Epub 2016 Oct 24. PMID: 28255434; PMCID: PMC5315223.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

[No authors listed]
PMID: 27392998
Therapie. 2008 Jan-Feb;63(1):75. doi: 10.2515/therapie:2008012.

No abstract available.

Cite
Practical Drug Safety from A to Z. Barton Cobert & Pierre Biron Boston : Jones & Bartlett; 2008 402 pages + CD ROM. [Not Available]. Therapie. 2008;63(1):75doi: 10.2515/therapie:2008012.
(2008). Practical Drug Safety from A to Z. Barton Cobert & Pierre Biron Boston : Jones & Bartlett; 2008 402 pages + CD ROM. [Not Available]. Therapie, 63(1), 75. https://doi.org/10.2515/therapie:2008012
"Practical Drug Safety from A to Z. Barton Cobert & Pierre Biron Boston : Jones & Bartlett; 2008 402 pages + CD ROM." [Not Available]. Therapie vol. 63,1 (2008): 75. doi: https://doi.org/10.2515/therapie:2008012
Practical Drug Safety from A to Z. Barton Cobert & Pierre Biron Boston : Jones & Bartlett; 2008 402 pages + CD ROM. [Not Available]. Therapie. 2008 Jan-Feb;63(1):75. doi: 10.2515/therapie:2008012. French. PMID: 27392998.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2125 entries